肝X受体
转分化
矽肺
转录因子
肌成纤维细胞
纤维化
基因沉默
癌症研究
过氧化物酶体增殖物激活受体
生物
ABCA1
细胞生物学
下调和上调
肺纤维化
内科学
病理
医学
核受体
干细胞
受体
生物化学
基因
运输机
作者
Yuanmeng Qi,Haichen Zhang,Hui Fan,Xinyu Wang,Ahui Zhao,Yangyang Tian,Guo Yang,Chao Li,Jingjing Wei,Wu Yao,Changfu Hao
标识
DOI:10.1016/j.envpol.2021.118272
摘要
Silicosis is a disease mainly caused by pulmonary interstitial fibrosis caused by long-term inhalation of dust with excessively high content of free SiO2. Transdifferentiation of lung fibroblasts into myofibroblasts is an important cellular basis for silicosis, but the key transcription factors (TFs) involved in this process are still unclear. In order to explore the biological regulation of transcription factor PPARγ/LXRα in silica-induced pulmonary fibrosis, this study explored the molecular mechanism of PPARγ/LXRα involved in regulating transcription factors related to SiO2-induced lung injury at the cellular level and in animal models. ChIP-qPCR detected that PPARγ directly regulated the transcriptional activity of the LXRα gene promoter, while the PPARγ agonist RSG increased the expression of LXRα. In addition, we demonstrated in the cell model that upregulation of LXRα can inhibit silica-mediated fibroblast transdifferentiation, accompanied by an increase in the expression of SREBF1, PLTP and ABCA1. The results of LXRα silencing experiment matched those of overexpression experiment. These studies explored the role of LXRα in plasticity and phenotypic transformation between lung fibroblasts and myofibroblasts. Therefore, inhibiting or reversing the transdifferentiation of lung fibroblasts to myofibroblasts by intervening PPARγ/LXRα may provide a new therapeutic target for the treatment of silicosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI